• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

AAO-HNSF 2012: Choosing an Effective Topical Agent to Treat Chronic Rhinosinusitis

by Thomas R. Collins • October 1, 2012

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

They’ve also identified three genes that seem to be related to the formation of the biofilm. “Alteration of this gene expression may well be involved in the innate immune system, and the greatest changes we’ve seen are in the S. aureus biofilm patients,” he said. “We may well have an innate immune defect” that contributes to the biofilm formation.

You Might Also Like

  • Is Cocaine a Safe Topical Agent For Use During Endoscopic Sinus Surgery?
  • AAO-HNSF 2012: Otolaryngologists Can Play a Larger Role in Treating Chronic Cough
  • Is Topical Amphotericin B Efficacious in the Treatment of Chronic Rhinosinusitis?
  • AAO-HNSF 2012: Challenging Vocal Fold Paralysis Cases
Explore This Issue
October 2012

Another potential agent, though still in the early stages of evaluation, is a mix of polyhydrated ionogen solution, which has its origins in an American Indian wound dressing involving boiled red oak tree bark and magnesium bromide, a compound that was abundant in the salt deposits used by ancient Egyptians to rejuvenate the skin. Once the product, marketed under the name RhinActive, was found to be nontoxic, it was tested for sinonasal mucosal healing in rabbits, with one side of a rabbit’s snout treated with the agent and the other side with saline, said Noam Cohen, MD, PhD, director of rhinology research at the University of Pennsylvania in Philadelphia. Daily irrigation for two weeks accelerated mucosal healing with well-differentiated ciliated cells. But Dr. Cohen cautioned that the evaluation so far has only been done in cavities that are not inflamed or infected, and the findings need to be confirmed in humans. “We are looking to start doing some clinical trials with it,” he said. “We have to see if it’s going to have the same type of potency in an infected, post-surgical individual.”

Container Contamination

The quality of topical agents is constantly being improved, but what about the containers used to deliver them? Contamination rates are surprisingly high, said Alkis Psaltis, MD, PhD, a fellow in rhinology and skull base surgery with Dr. Schlosser at the Medical University of South Carolina. Studies have found that bacterial contamination can linger in more than half of bottles that have been cleaned with hot, soapy water or detergent and allowed to air dry, Dr. Psaltis said.

A 2011 study found that just five out of 20 patients sterilized their bottles after every use, and most continued to use the same bottle for 12 months, far longer than the recommended three months, he said (Int Forum Allergy Rhinol. 2011;1(4):303-307).

But, Dr. Psaltis asked, “Does this contamination actually translate into clinical infections?” Two studies have found that the contaminations are not reflected in actual patient infections (Am J Rhinol Allergy. 2009;23(4):401-404; Am J Rhinol Allergy. 2010;24(3):197-199). “I suppose this is an important finding,” he said, “because we know that irrigation is a very effective and safe treatment for our patients. And advising patients against irrigating their nose may do more harm than good.”

Pages: 1 2 3 4 | Single Page

Filed Under: Practice Focus, Rhinology Tagged With: chronic rhinosinusitis, rhinosinusitis, Sinusitis, topical agents, treatmentIssue: October 2012

You Might Also Like:

  • Is Cocaine a Safe Topical Agent For Use During Endoscopic Sinus Surgery?
  • AAO-HNSF 2012: Otolaryngologists Can Play a Larger Role in Treating Chronic Cough
  • Is Topical Amphotericin B Efficacious in the Treatment of Chronic Rhinosinusitis?
  • AAO-HNSF 2012: Challenging Vocal Fold Paralysis Cases

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Journey Through Pay Inequity: A Physician’s Firsthand Account

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939